Actinium Pharmaceuticals Provides Update on Actimab-A Phase 2 Clinical Trial for Patients with Acute Myeloid Leukemia Oct 4, 2017
Actinium Pharmaceuticals to Participate in American Society for Blood and Marrow Transplantation 2017 Corporate Council Meeting Sep 20, 2017
Actinium Pharmaceuticals Highlights Presence at the Society of Hematologic Oncology 2017 Annual Meeting Sep 13, 2017
Actinium Pharmaceuticals to Participate in the Oppenheimer & Co. Boston Oncology Insights Summit on August 16-17, 2017 Aug 9, 2017
Actinium Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock Aug 2, 2017
Actinium Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock Jul 28, 2017
Actinium Announces Proposed Public Offering of Common Stock and Warrants to Purchase Stock Jul 27, 2017
Actinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ET Jul 13, 2017
Actinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ET Jul 6, 2017
